University of Surrey leader appointed to the Board of the Pirbright Institute
Professor Vince Emery, Senior Vice-President (Global) at the University of Surrey has been appointed as a Trustee Director of the Pirbright Institute.
The Pirbright Institute is the world's leading centre for the prevention and control of viral diseases of livestock. As an independent company, limited by guarantee, and a registered charity, the Institute is governed by a Board of non-executive Trustee Directors.
Professor Emery said:
“It is a great honour and privilege to become one of the Trustee Directors of the Pirbright Institute. I am looking forward to contributing both my extensive experience as a virologist and my expertise in global relationship building to supporting the effectiveness of the Board and advancing the mission of the Institute”.
Professor Max Lu, President and Vice-Chancellor of the University of Surrey, said:
“This is a great and well-deserved accolade for Professor Emery. His appointment adds further substance to the already close working relationship between the University of Surrey, our acclaimed School of Veterinary Medicine and the Pirbright Institute. As two leading centres of global scientific excellence we share many areas of common interest, and we look forward to deepening this relationship in a range of scientific pursuits”.
Students and researchers at the University of Surrey benefit from the close working relationship between the Pirbright Institute and the School of Veterinary Medicine – with some courses including extended visits to the Institute, dissertation projects offered by the Institute and Professional Training Year opportunities.
Professor Vince Emery
Vince Emery is Senior Vice-President (Global) and Professor of Translational Virology at the University of Surrey. Professor Emery leads the University of Surrey's global strategy seeking to catalyse and expand international research networks, student and staff recruitment and mobility, to foster teaching collaborations, and to realise transnational educational opportunities.
Vince started his scientific career as a biochemist but has been a virologist for the last 32 years. His current research aims to provide an interdisciplinary approach to understanding viral infections in immunocompromised hosts such as HIV-infected patients and transplant recipients. He is also Deputy Director of I-sense which is developing early warning sensing systems for infectious diseases and is supported through multi million pound grant support from EPSRC (www.i-sense.org.uk)